Potential value of myocardial contrast echocardiography for the detection of myocardial fibrosis in hypertrophic cardiomyopathy

Arch Cardiovasc Dis. 2011 Dec;104(12):682-3. doi: 10.1016/j.acvd.2011.03.092. Epub 2011 Nov 18.

Authors

Aurélie Chaudeurge¹, Philippe Garçon, Romain Cador

Affiliation

¹ Cardiology Department, Fondation hôpital Saint-Joseph, 185, rue Raymond-Losserand, 75014 Paris, France. [email protected]

PMID: 22152520
DOI: 10.1016/j.acvd.2011.03.092

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Cardiomyopathy, Hypertrophic / diagnostic imaging*
Cardiomyopathy, Hypertrophic / pathology
Contrast Media*
Fibrosis
Humans
Hypertrophy, Left Ventricular / diagnostic imaging
Hypertrophy, Left Ventricular / pathology
Magnetic Resonance Imaging
Male
Myocardium / pathology*
Phospholipids*
Predictive Value of Tests
Sulfur Hexafluoride*
Ultrasonography

Substances

Contrast Media
Phospholipids
contrast agent BR1
Sulfur Hexafluoride